DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis

被引:102
作者
Delogu, G [1 ]
Li, A [1 ]
Repique, C [1 ]
Collins, F [1 ]
Morris, SL [1 ]
机构
[1] US FDA, LMDCI, OVRR, CBER, Bethesda, MD 20892 USA
关键词
D O I
10.1128/IAI.70.1.292-302.2002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
DNA vaccination has emerged as a powerful approach in the search for a more efficacious vaccine against tuberculosis. In this study, we evaluated the effectiveness of immunizing with combinations of 10 different tuberculosis DNA vaccines that expressed mycobacterial proteins fused at the N terminus to eukaryotic intracellular targeting sequences. In one vaccine combination, the genes were fused to the tissue plasminogen activator signal sequence (TPA), while in a second combination the same 10 genes were expressed as ubiquitin (Ub)-conjugated proteins. In ex vivo studies in which the secretion of gamma interferon was measured, cellular immune responses were detected in mice vaccinated with either the TPA DNA vaccine combination or the Ub DNA vaccine combination at 7 and 14 days following a low-dose Mycobacterium tuberculosis challenge. Moreover, mice vaccinated with the TPA combination, the Ub combination, and Mycobacterium bovis BCG were able to limit the growth of tubercle bacilli in the lung and spleen after a virulent tuberculous aerosol challenge. Histopathological analyses also showed that mice immunized with the DNA vaccine combinations had substantially improved postinfection lung pathology relative to the naive controls. Finally, in three different long-term experiments, the survival periods following aerogenic challenge were extended as much as sevenfold for vaccinated mice compared to naive controls. Interestingly, in all three experiments, no significant differences were detected in the mean times to death for mice immunized with the TPA combination or the Ub combination relative to the BCG controls. In conclusion, these studies demonstrate the effectiveness of immunization with DNA vaccine combinations against tuberculosis and suggest that further testing of these plasmid cocktails is warranted.
引用
收藏
页码:292 / 302
页数:11
相关论文
共 42 条
[1]   Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine [J].
An, LL ;
Rodriguez, F ;
Harkins, S ;
Zhang, J ;
Whitton, JL .
VACCINE, 2000, 18 (20) :2132-2141
[2]   Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis [J].
Andersen, P .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 45 (02) :115-131
[3]   Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis [J].
Baldwin, SL ;
D'Souza, C ;
Roberts, AD ;
Kelly, BP ;
Frank, AA ;
Lui, MA ;
Ulmer, JB ;
Huygen, K ;
McMurray, DM ;
Orme, IM .
INFECTION AND IMMUNITY, 1998, 66 (06) :2951-2959
[4]   Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways [J].
Castellino, F ;
Boucher, PE ;
Eichelberg, K ;
Mayhew, M ;
Rothman, JE ;
Houghton, AN ;
Germain, RN .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (11) :1957-1964
[5]   EFFICACY OF BCG VACCINE IN THE PREVENTION OF TUBERCULOSIS - METAANALYSIS OF THE PUBLISHED LITERATURE [J].
COLDITZ, GA ;
BREWER, TF ;
BERKEY, CS ;
WILSON, ME ;
BURDICK, E ;
FINEBERG, HV ;
MOSTELLER, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09) :698-702
[6]   Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence [J].
Cole, ST ;
Brosch, R ;
Parkhill, J ;
Garnier, T ;
Churcher, C ;
Harris, D ;
Gordon, SV ;
Eiglmeier, K ;
Gas, S ;
Barry, CE ;
Tekaia, F ;
Badcock, K ;
Basham, D ;
Brown, D ;
Chillingworth, T ;
Connor, R ;
Davies, R ;
Devlin, K ;
Feltwell, T ;
Gentles, S ;
Hamlin, N ;
Holroyd, S ;
Hornby, T ;
Jagels, K ;
Krogh, A ;
McLean, J ;
Moule, S ;
Murphy, L ;
Oliver, K ;
Osborne, J ;
Quail, MA ;
Rajandream, MA ;
Rogers, J ;
Rutter, S ;
Seeger, K ;
Skelton, J ;
Squares, R ;
Squares, S ;
Sulston, JE ;
Taylor, K ;
Whitehead, S ;
Barrell, BG .
NATURE, 1998, 393 (6685) :537-+
[7]  
Coler RN, 1998, J IMMUNOL, V161, P2356
[8]  
Collins F M, 1970, Cell Immunol, V1, P253, DOI 10.1016/0008-8749(70)90047-X
[9]   PROTECTION TO MICE AFFORDED BY BCG VACCINES AGAINST AN AEROGENIC CHALLENGE BY 3 MYCOBACTERIA OF DECREASING VIRULENCE [J].
COLLINS, FM .
TUBERCLE, 1985, 66 (04) :267-276
[10]  
Corr M, 1999, J IMMUNOL, V163, P4721